The Technology of Circulating Tumor DNA by Department of Pathology of Second Xiangya Hospital Has Passed External Quality Assessment
On May 15, Department of Pathology of the Second Xiangya Hospital of Central South University passed 2022 External Quality Assessment (EQA) of European Molecular Genetics Quality Network (EMQN), involving five next-generation sequencing (NGS) schemes, and was awarded the certi...












